Global expansion Novogene America is actively expanding with new offices in Australia and Beaverton Oregon, indicating growth in capacity and regional coverage. This presents opportunities to cross-sell expanded sequencing services, multi-omics workflows, and collaborative R&D programs to new and existing regional clients.

Expanded service lines Recent launches include untargeted metabolomics, DIA quantitative proteomics, and Stereo-Seq spatial technologies, signaling a broader toolbox for clients across biomarker discovery, systems biology, and translational research. Sales opportunities exist in offering end-to-end multi-omics solutions and integration with clients’ pipelines.

High throughput capability With the world’s largest sequencing capacity and multiple platforms (Illumina, PacBio, Nanopore), Novogene can handle large-scale projects and keep fast turnaround times, appealing to customers with big data needs and time-sensitive research programs.

Academic and biotech partnerships Strong track record of collaboration with US and worldwide scientists and presence at conferences suggests ample opportunities to engage academic labs, biotech startups, and contract research organizations for research services, collaborations, and sponsored projects.

Publications and credibility A robust output of SCI articles across prestigious journals reinforces credibility for prospective clients seeking validated genomic and multi-omics data generation. Leverage this to support proposals, case studies, and proof-of-value in sales conversations.